Gobbo, Angélica Rita; Bouth, Raquel Carvalho; Moraes, Tania Mara Pires; Pinto, Pablo; Costa, Patricia Fagundes da; Barreto, Josafá Gonçalves; Frade, Marco Andrey Cipriani 
; Ribeiro-dos-Santos, Andrea K. C.; Conde, Guilherme Augusto Barros; Duthie, Malcolm S.; Silva, Moisés Batista da; Spencer, John Stewart; Salgado, Claudio Guedes
Source: Frontiers in Tropical Diseases. Unidade: FMRP
Subjects: HANSENÍASE, TESTES SOROLÓGICOS, DIAGNÓSTICO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOBBO, Angélica Rita et al. NDO-BSA, LID-1, and NDO-LID antibody responses for infection and RLEP by quantitative PCR as a confirmatory test for early leprosy diagnosis. Frontiers in Tropical Diseases, v. 3, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.3389/fitd.2022.850886. Acesso em: 24 jan. 2026.APA
Gobbo, A. R., Bouth, R. C., Moraes, T. M. P., Pinto, P., Costa, P. F. da, Barreto, J. G., et al. (2022). NDO-BSA, LID-1, and NDO-LID antibody responses for infection and RLEP by quantitative PCR as a confirmatory test for early leprosy diagnosis. Frontiers in Tropical Diseases, 3, 1-10. doi:10.3389/fitd.2022.850886NLM
Gobbo AR, Bouth RC, Moraes TMP, Pinto P, Costa PF da, Barreto JG, Frade MAC, Ribeiro-dos-Santos AKC, Conde GAB, Duthie MS, Silva MB da, Spencer JS, Salgado CG. NDO-BSA, LID-1, and NDO-LID antibody responses for infection and RLEP by quantitative PCR as a confirmatory test for early leprosy diagnosis [Internet]. Frontiers in Tropical Diseases. 2022 ; 3 1-10.[citado 2026 jan. 24 ] Available from: https://doi.org/10.3389/fitd.2022.850886Vancouver
Gobbo AR, Bouth RC, Moraes TMP, Pinto P, Costa PF da, Barreto JG, Frade MAC, Ribeiro-dos-Santos AKC, Conde GAB, Duthie MS, Silva MB da, Spencer JS, Salgado CG. NDO-BSA, LID-1, and NDO-LID antibody responses for infection and RLEP by quantitative PCR as a confirmatory test for early leprosy diagnosis [Internet]. Frontiers in Tropical Diseases. 2022 ; 3 1-10.[citado 2026 jan. 24 ] Available from: https://doi.org/10.3389/fitd.2022.850886
